MedWatch

New share split beefs up acquisition power, says Lundbeck EVP

Lundbeck’s new share structure, which came into effect earlier this month, increases the firm’s acquisition capabilities should the right opportunity arise, says EVP and Head of R&D Johan Luthman.

Johan Luthman, executive vice president and head of research and development at Lundbeck | Photo: PR / Lundbeck

In June, the Lundbeck Foundation implemented a new share structure meaning that all existing Lundbeck shares have been split into five – one A share and four B shares.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs